Respiratory Diagnostics After COVID: How Devansh Lab Werks is Equipping Providers with Smarter qPCR Testing

Jul 2, 2025 - 17:21
 2
Respiratory Diagnostics After COVID: How Devansh Lab Werks is Equipping Providers with Smarter qPCR Testing

Introduction
The COVID-19 pandemic reshaped how the world views respiratory infections. While SARS-CoV-2 has become more manageable, providers still face a common issue: overlapping symptoms between COVID-19, influenza, RSV, and other pathogens. Accurate diagnostics are essential—and fast.

Devansh Lab Werks (DLW), a CLIA-certified lab in the U.S., is delivering precise, high-throughput qPCR-based respiratory pathogen panels to help healthcare professionals respond swiftly and confidently.

 

1. The Post-Pandemic Diagnostic Challenge
Patients now present with symptoms that could signal a range of infections:

  • Fever

  • Cough

  • Shortness of breath

  • Fatigue

Is it COVID? Flu? RSV? Or something bacterial? Guesswork can delay proper treatment and increase transmission risk. DLW’s multi-pathogen respiratory panel helps differentiate these quickly, guiding more appropriate care.

See DLW's Respiratory Pathogen Panel →

 

2. What Makes DLW’s qPCR Panels Stand Out?
DLW's respiratory panel uses real-time polymerase chain reaction (qPCR) to detect multiple viral and bacterial pathogens from a single sample. These include:

  • SARS-CoV-2

  • Influenza A & B

  • RSV

  • Rhinovirus/Enterovirus

  • Adenovirus

  • Mycoplasma pneumoniae

  • Bordetella pertussis

Advantages:

  • High sensitivity and specificity

  • Rapid turnaround (within 24–48 hours)

  • One swab = 20+ pathogens

  • Ideal for clinics, schools, long-term care, urgent care

 

3. The Workflow: Simple, Scalable, Smart

Step 1: Physician orders test via DLW portal or intake form
Step 2: Sample collected via mobile phlebotomy or in-facility draw
Step 3: Sample processed at DLW’s certified lab
Step 4: Results delivered securely via HIPAA-compliant portal

DLW supports both high-volume clients and one-off requests, making it scalable for every organization.

Schedule a Demo →

 

4. Real-Life Clinical Use Cases

  • Pediatrics: Differentiating RSV from flu in children for faster treatment plans

  • Geriatric Clinics: Monitoring immunocompromised or elderly patients for multiple pathogens

  • Employers/Workplace Clinics: Reducing absenteeism and transmission risk

  • Telehealth Support: Matching symptoms with rapid at-home phlebotomy + qPCR diagnostics

"We use DLW’s respiratory panel weekly during flu season—it’s a game-changer for triage."
— Clinical Manager, Family Health Network, TX

 

5. Better Outcomes, Lower Costs

  • Reduce ER admissions from misdiagnosis

  • Avoid unnecessary antibiotics

  • Improve turnaround time for viral treatment initiation (e.g., Tamiflu)

  • Minimize community spread through faster isolation

 

6. How to Get Started DLW makes onboarding easy:

  • Create a provider account and choose preferred test volume

  • Access supply kits and training if needed

  • Begin scheduling draws or sending samples for qPCR testing

Conclusion: Testing Smarter in the New Normal
Respiratory infections aren’t going away—but the guessing can. With DLW’s high-precision qPCR pathogen panels, healthcare providers can treat quickly, isolate responsibly, and protect their communities better than ever.

When symptoms blur, diagnostics clarify. Let Devansh Lab Werks help you bring clarity to care.